Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News ENDRA Life Sciences Inc NDRA

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into... see more

Recent & Breaking News (NDAQ:NDRA)

ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update

Business Wire November 14, 2022

ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022

Business Wire November 9, 2022

ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents

Business Wire October 25, 2022

ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference

Business Wire October 4, 2022

ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks

Business Wire September 29, 2022

ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences

Business Wire September 6, 2022

ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System

Business Wire August 24, 2022

ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Business Wire August 15, 2022

ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022

Business Wire August 4, 2022

ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices

Business Wire August 2, 2022

ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

Business Wire August 1, 2022

ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System

Business Wire July 11, 2022

ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent

Business Wire June 28, 2022

ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference

Business Wire June 8, 2022

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent

Business Wire May 25, 2022

ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference

Business Wire May 16, 2022

ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update

Business Wire May 12, 2022

ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System

Business Wire May 10, 2022

ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022

Business Wire May 2, 2022

ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility

Business Wire April 21, 2022